Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8759401 | AKORN | Aqueous gel formulation and method for inducing topical anesthesia |
Jul, 2026
(3 years from now) |
Market Authorisation Date: 07 October, 2008
Treatment: Method of inducing topical anesthesia in the eye
Dosage: GEL;OPHTHALMIC
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8540665 | POWDER PHARMS | Particle cassettes and processes therefor |
Oct, 2029
(6 years from now) | |
US9358338 | POWDER PHARMS | Particle cassettes and processes therefor |
Apr, 2035
(12 years from now) | |
US9370622 | POWDER PHARMS | Devices and methods for delivering particles |
Sep, 2035
(12 years from now) |
Market Authorisation Date: 16 August, 2007
Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intradermal system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action
Dosage: SYSTEM;INTRADERMAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic